JPH08507782A - 記憶障害および学習障害の治療のためのトリアジン化合物の使用 - Google Patents
記憶障害および学習障害の治療のためのトリアジン化合物の使用Info
- Publication number
- JPH08507782A JPH08507782A JP6520807A JP52080794A JPH08507782A JP H08507782 A JPH08507782 A JP H08507782A JP 6520807 A JP6520807 A JP 6520807A JP 52080794 A JP52080794 A JP 52080794A JP H08507782 A JPH08507782 A JP H08507782A
- Authority
- JP
- Japan
- Prior art keywords
- memory
- learning
- dichlorophenyl
- disorders
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.記憶障害あるいは学習障害の治療用薬剤の製造のための、3,5−ジアミ ノ−6−(2,3−ジクロロフェニル)−1,2,4−トリアジンまたはその製 薬上あるいは獣医学上容認しうる酸付加塩の使用。 2.3,5−ジアミノ−6−(2,3−ジクロロフェニル)−1,2,4−ト リアジンイセチオン酸塩の、請求項1記載の使用。 3.記憶障害あるいは学習障害は痴呆と関係がある、請求項1あるいは請求項 2記載の使用。 4.記憶障害あるいは学習障害は、アルツハイマー病またはアルツハイマー型 老年性痴呆と関係がある、請求項1、請求項2あるいは請求項3記載の使用。 5.記憶障害あるいは学習障害は、多梗塞痴呆またはクロイツフェルト−ヤコ ブ病と関係がある、請求項1、請求項2または請求項3記載の使用。 6.記憶障害あるいは学習障害は脳損傷の結果である、請求項1または請求項 2記載の使用。 7.記憶障害あるいは学習障害は、発作、麻酔事故、頭部外傷、低血糖症、一 酸化炭素中毒、リチウム中毒、ビタミン欠乏または過度のアルコール飲用の結果 である、請求項1、請求項2または請求項6記載の使用。 8.記憶障害あるいは学習障害は年齢と関係があるか、コルサコフ病と関係が あるか、あるいは電気けいれん療法による結果である、請求項1または請求項2 記載の使用。 9.哺乳動物における記憶障害あるいは学習障害の治療法において、3,5− ジアミノ−6−(2,3−ジクロロフェニル)−1,2,4−トリアジンならび にその製薬上および獣医学上容認しうる酸付加塩から選ばれる化合物の治療上有 効な量を哺乳動物へ投与することからなる上記方法。 10.哺乳動物はヒトである、請求項9記載の方法。 11.記憶障害あるいは学習障害の治療用薬剤において、3,5−ジアミノ−6 −(2,3−ジクロロフェニル)−1,2,4−トリアジンあるいはその製薬上 または獣医学上容認しうる酸付加塩を含有してなる上記薬剤。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9305693.5 | 1993-03-19 | ||
GB939305693A GB9305693D0 (en) | 1993-03-19 | 1993-03-19 | Therapeutic triazine compounds and use |
PCT/GB1994/000559 WO1994021260A1 (en) | 1993-03-19 | 1994-03-18 | Use of triazine compounds for the treatment of memory and learning disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH08507782A true JPH08507782A (ja) | 1996-08-20 |
Family
ID=10732358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6520807A Ceased JPH08507782A (ja) | 1993-03-19 | 1994-03-18 | 記憶障害および学習障害の治療のためのトリアジン化合物の使用 |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0689439B1 (ja) |
JP (1) | JPH08507782A (ja) |
AP (1) | AP478A (ja) |
AT (1) | ATE198831T1 (ja) |
AU (1) | AU6217694A (ja) |
DE (1) | DE69426622T2 (ja) |
DK (1) | DK0689439T3 (ja) |
ES (1) | ES2153854T3 (ja) |
GB (1) | GB9305693D0 (ja) |
GR (1) | GR3035528T3 (ja) |
IL (1) | IL109034A (ja) |
PT (1) | PT689439E (ja) |
TW (1) | TW256773B (ja) |
WO (1) | WO1994021260A1 (ja) |
ZA (1) | ZA941938B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9424766D0 (en) * | 1994-12-07 | 1995-02-08 | Wellcome Found | Pharmaceutical composition |
DE19603984A1 (de) * | 1996-02-05 | 1997-08-07 | Bayer Ag | Granulate von Triazinen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU530999B2 (en) * | 1979-06-01 | 1983-08-04 | Wellcome Foundation Limited, The | Substituted amino triazines and their use in treatment of cns disorders |
GB8613183D0 (en) * | 1986-05-30 | 1986-07-02 | Wellcome Found | Triazine salt |
JP2632754B2 (ja) * | 1991-05-21 | 1997-07-23 | 塩野義製薬株式会社 | 脳内グルタミン酸遊離抑制剤 |
-
1993
- 1993-03-19 GB GB939305693A patent/GB9305693D0/en active Pending
-
1994
- 1994-03-18 DK DK94909263T patent/DK0689439T3/da active
- 1994-03-18 AP APAP/P/1994/000627A patent/AP478A/en active
- 1994-03-18 WO PCT/GB1994/000559 patent/WO1994021260A1/en active IP Right Grant
- 1994-03-18 DE DE69426622T patent/DE69426622T2/de not_active Expired - Fee Related
- 1994-03-18 ZA ZA941938A patent/ZA941938B/xx unknown
- 1994-03-18 AU AU62176/94A patent/AU6217694A/en not_active Abandoned
- 1994-03-18 IL IL10903494A patent/IL109034A/en active IP Right Grant
- 1994-03-18 TW TW083102373A patent/TW256773B/zh active
- 1994-03-18 AT AT94909263T patent/ATE198831T1/de not_active IP Right Cessation
- 1994-03-18 PT PT94909263T patent/PT689439E/pt unknown
- 1994-03-18 EP EP94909263A patent/EP0689439B1/en not_active Expired - Lifetime
- 1994-03-18 ES ES94909263T patent/ES2153854T3/es not_active Expired - Lifetime
- 1994-03-18 JP JP6520807A patent/JPH08507782A/ja not_active Ceased
-
2001
- 2001-03-08 GR GR20010400367T patent/GR3035528T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AP9400627A0 (en) | 1994-04-30 |
DK0689439T3 (da) | 2001-04-17 |
ES2153854T3 (es) | 2001-03-16 |
AP478A (en) | 1996-03-08 |
DE69426622T2 (de) | 2001-06-21 |
TW256773B (ja) | 1995-09-11 |
PT689439E (pt) | 2001-05-31 |
EP0689439A1 (en) | 1996-01-03 |
EP0689439B1 (en) | 2001-01-24 |
AU6217694A (en) | 1994-10-11 |
WO1994021260A1 (en) | 1994-09-29 |
GR3035528T3 (en) | 2001-06-29 |
IL109034A0 (en) | 1994-06-24 |
ATE198831T1 (de) | 2001-02-15 |
IL109034A (en) | 1998-12-06 |
ZA941938B (en) | 1995-09-18 |
GB9305693D0 (en) | 1993-05-05 |
DE69426622D1 (de) | 2001-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101918745B1 (ko) | 바클로펜 및 아캄프로세이트에 기초한 신경 장애의 치료 | |
EP0387867A1 (en) | Composition containing D-cycloserine and D-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder | |
US20080226718A1 (en) | Indole and Azaindole Derivatives For the Treatment of Inflammatory and Autoimmune Diseases | |
HU202108B (en) | Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol | |
CA2601509A1 (en) | Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions | |
US20230270753A1 (en) | Combinations of gabaa alpha 5 agonists and sv2a inhibitors and methods of using in the treatment of cognitive impairment | |
KR20080105105A (ko) | 인지 장애 및 기타 장애의 치료방법 | |
JPH0667842B2 (ja) | 基本的うつ病を軽減するためのうつ病治療剤 | |
EP1020189B1 (en) | Nefiracetam for prevention and treatment of amnesia caused by propofol | |
WO2024016996A1 (zh) | 磷酸萘酚喹在制备治疗自身免疫性疾病药物中的应用 | |
JPH10512269A (ja) | 大脳の変性疾患の治療または予防用の医薬組成物の製造のための3,4−ジフェニルクロマンの使用 | |
CA2362918A1 (en) | Methods and compositions for treating erectile dysfunction | |
JPH08507782A (ja) | 記憶障害および学習障害の治療のためのトリアジン化合物の使用 | |
WO2019171333A1 (en) | Treatment of demyelinating diseases | |
JP5299949B2 (ja) | シロスタゾールの統合失調症治療剤 | |
JP2005501108A (ja) | 神経変性治療におけるネフィラセタムの使用 | |
US5866597A (en) | Use of triazine compounds for the treatment of memory and learning disorders | |
RU2277096C2 (ru) | Средства против слабоумия, содержащие производное 2-арил-8-оксодигидропурина в качестве активного ингредиента | |
WO2019171332A1 (en) | Treatment of demyelinating diseases | |
IL309770A (en) | NK1 antagonist combination and a method for the treatment of synucleinopathies | |
RU2805061C2 (ru) | Лечение демиелинизирующих заболеваний | |
JP2003221337A (ja) | 酢酸アミド誘導体を有効成分とする痴呆症治療剤 | |
JP2000204041A (ja) | 薬物依存症治療剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041207 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050307 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050418 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050607 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20051004 |
|
A045 | Written measure of dismissal of application [lapsed due to lack of payment] |
Free format text: JAPANESE INTERMEDIATE CODE: A045 Effective date: 20060221 |